nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.192	0.463	CbGbCtD
Temozolomide—CYP3A4—Progesterone—uterine cancer	0.127	0.307	CbGbCtD
Temozolomide—CYP3A4—Etoposide—uterine cancer	0.057	0.137	CbGbCtD
Temozolomide—CYP3A4—Doxorubicin—uterine cancer	0.0389	0.0936	CbGbCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000355	0.000607	CcSEcCtD
Temozolomide—Discomfort—Etoposide—uterine cancer	0.000353	0.000604	CcSEcCtD
Temozolomide—Breast disorder—Epirubicin—uterine cancer	0.000353	0.000604	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000352	0.000602	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000352	0.000602	CcSEcCtD
Temozolomide—Face oedema—Doxorubicin—uterine cancer	0.000349	0.000597	CcSEcCtD
Temozolomide—Hypersensitivity—Dactinomycin—uterine cancer	0.000348	0.000596	CcSEcCtD
Temozolomide—Confusional state—Etoposide—uterine cancer	0.000345	0.000591	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000344	0.000589	CcSEcCtD
Temozolomide—Muscular weakness—Epirubicin—uterine cancer	0.000344	0.000589	CcSEcCtD
Temozolomide—Anaphylactic shock—Etoposide—uterine cancer	0.000342	0.000586	CcSEcCtD
Temozolomide—Mood swings—Doxorubicin—uterine cancer	0.000342	0.000586	CcSEcCtD
Temozolomide—Infection—Etoposide—uterine cancer	0.00034	0.000582	CcSEcCtD
Temozolomide—Abdominal distension—Epirubicin—uterine cancer	0.00034	0.000581	CcSEcCtD
Temozolomide—Ataxia—Doxorubicin—uterine cancer	0.00034	0.000581	CcSEcCtD
Temozolomide—Asthenia—Dactinomycin—uterine cancer	0.000339	0.000581	CcSEcCtD
Temozolomide—Dysphagia—Epirubicin—uterine cancer	0.000337	0.000577	CcSEcCtD
Temozolomide—Dehydration—Doxorubicin—uterine cancer	0.000336	0.000575	CcSEcCtD
Temozolomide—Thrombocytopenia—Etoposide—uterine cancer	0.000335	0.000573	CcSEcCtD
Temozolomide—Skin disorder—Etoposide—uterine cancer	0.000332	0.000569	CcSEcCtD
Temozolomide—Dry skin—Doxorubicin—uterine cancer	0.000331	0.000567	CcSEcCtD
Temozolomide—Hyperhidrosis—Etoposide—uterine cancer	0.000331	0.000566	CcSEcCtD
Temozolomide—Hypokalaemia—Doxorubicin—uterine cancer	0.000329	0.000562	CcSEcCtD
Temozolomide—Breast disorder—Doxorubicin—uterine cancer	0.000326	0.000559	CcSEcCtD
Temozolomide—Anorexia—Etoposide—uterine cancer	0.000326	0.000558	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000325	0.000557	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000325	0.000557	CcSEcCtD
Temozolomide—Bronchitis—Epirubicin—uterine cancer	0.000325	0.000555	CcSEcCtD
Temozolomide—Diarrhoea—Dactinomycin—uterine cancer	0.000324	0.000554	CcSEcCtD
Temozolomide—Pancytopenia—Epirubicin—uterine cancer	0.00032	0.000548	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000319	0.000545	CcSEcCtD
Temozolomide—Muscular weakness—Doxorubicin—uterine cancer	0.000319	0.000545	CcSEcCtD
Temozolomide—Dysuria—Epirubicin—uterine cancer	0.000316	0.00054	CcSEcCtD
Temozolomide—Neutropenia—Epirubicin—uterine cancer	0.000316	0.00054	CcSEcCtD
Temozolomide—Abdominal distension—Doxorubicin—uterine cancer	0.000314	0.000538	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000314	0.000537	CcSEcCtD
Temozolomide—Dysphagia—Doxorubicin—uterine cancer	0.000312	0.000534	CcSEcCtD
Temozolomide—Pollakiuria—Epirubicin—uterine cancer	0.000312	0.000533	CcSEcCtD
Temozolomide—Photosensitivity reaction—Epirubicin—uterine cancer	0.000308	0.000527	CcSEcCtD
Temozolomide—Paraesthesia—Etoposide—uterine cancer	0.000307	0.000526	CcSEcCtD
Temozolomide—Weight increased—Epirubicin—uterine cancer	0.000307	0.000525	CcSEcCtD
Temozolomide—Weight decreased—Epirubicin—uterine cancer	0.000305	0.000522	CcSEcCtD
Temozolomide—Dyspnoea—Etoposide—uterine cancer	0.000305	0.000522	CcSEcCtD
Temozolomide—Hyperglycaemia—Epirubicin—uterine cancer	0.000304	0.000521	CcSEcCtD
Temozolomide—Somnolence—Etoposide—uterine cancer	0.000304	0.000521	CcSEcCtD
Temozolomide—Pneumonia—Epirubicin—uterine cancer	0.000303	0.000518	CcSEcCtD
Temozolomide—Infestation NOS—Epirubicin—uterine cancer	0.000301	0.000515	CcSEcCtD
Temozolomide—Infestation—Epirubicin—uterine cancer	0.000301	0.000515	CcSEcCtD
Temozolomide—Vomiting—Dactinomycin—uterine cancer	0.000301	0.000515	CcSEcCtD
Temozolomide—Bronchitis—Doxorubicin—uterine cancer	0.0003	0.000514	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000298	0.00051	CcSEcCtD
Temozolomide—Rash—Dactinomycin—uterine cancer	0.000298	0.00051	CcSEcCtD
Temozolomide—Decreased appetite—Etoposide—uterine cancer	0.000298	0.000509	CcSEcCtD
Temozolomide—Pancytopenia—Doxorubicin—uterine cancer	0.000296	0.000507	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000296	0.000506	CcSEcCtD
Temozolomide—Fatigue—Etoposide—uterine cancer	0.000295	0.000505	CcSEcCtD
Temozolomide—Neuropathy peripheral—Epirubicin—uterine cancer	0.000295	0.000505	CcSEcCtD
Temozolomide—Stomatitis—Epirubicin—uterine cancer	0.000293	0.000502	CcSEcCtD
Temozolomide—Constipation—Etoposide—uterine cancer	0.000293	0.000501	CcSEcCtD
Temozolomide—Pain—Etoposide—uterine cancer	0.000293	0.000501	CcSEcCtD
Temozolomide—Urinary tract infection—Epirubicin—uterine cancer	0.000292	0.0005	CcSEcCtD
Temozolomide—Dysuria—Doxorubicin—uterine cancer	0.000292	0.0005	CcSEcCtD
Temozolomide—Neutropenia—Doxorubicin—uterine cancer	0.000292	0.0005	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00029	0.000496	CcSEcCtD
Temozolomide—Pollakiuria—Doxorubicin—uterine cancer	0.000288	0.000493	CcSEcCtD
Temozolomide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000285	0.000488	CcSEcCtD
Temozolomide—Hepatobiliary disease—Epirubicin—uterine cancer	0.000285	0.000487	CcSEcCtD
Temozolomide—Weight increased—Doxorubicin—uterine cancer	0.000284	0.000486	CcSEcCtD
Temozolomide—Weight decreased—Doxorubicin—uterine cancer	0.000282	0.000483	CcSEcCtD
Temozolomide—Sinusitis—Epirubicin—uterine cancer	0.000282	0.000483	CcSEcCtD
Temozolomide—Feeling abnormal—Etoposide—uterine cancer	0.000282	0.000483	CcSEcCtD
Temozolomide—Hyperglycaemia—Doxorubicin—uterine cancer	0.000282	0.000482	CcSEcCtD
Temozolomide—Nausea—Dactinomycin—uterine cancer	0.000281	0.000481	CcSEcCtD
Temozolomide—Pneumonia—Doxorubicin—uterine cancer	0.00028	0.000479	CcSEcCtD
Temozolomide—Gastrointestinal pain—Etoposide—uterine cancer	0.00028	0.000479	CcSEcCtD
Temozolomide—Infestation NOS—Doxorubicin—uterine cancer	0.000278	0.000476	CcSEcCtD
Temozolomide—Infestation—Doxorubicin—uterine cancer	0.000278	0.000476	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000276	0.000472	CcSEcCtD
Temozolomide—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000273	0.000467	CcSEcCtD
Temozolomide—Urticaria—Etoposide—uterine cancer	0.000272	0.000465	CcSEcCtD
Temozolomide—Haemoglobin—Epirubicin—uterine cancer	0.000271	0.000464	CcSEcCtD
Temozolomide—Stomatitis—Doxorubicin—uterine cancer	0.000271	0.000464	CcSEcCtD
Temozolomide—Abdominal pain—Etoposide—uterine cancer	0.000271	0.000463	CcSEcCtD
Temozolomide—Body temperature increased—Etoposide—uterine cancer	0.000271	0.000463	CcSEcCtD
Temozolomide—Urinary tract infection—Doxorubicin—uterine cancer	0.000271	0.000463	CcSEcCtD
Temozolomide—Haemorrhage—Epirubicin—uterine cancer	0.00027	0.000462	CcSEcCtD
Temozolomide—Hepatitis—Epirubicin—uterine cancer	0.00027	0.000462	CcSEcCtD
Temozolomide—Hypoaesthesia—Epirubicin—uterine cancer	0.000269	0.00046	CcSEcCtD
Temozolomide—Pharyngitis—Epirubicin—uterine cancer	0.000268	0.000459	CcSEcCtD
Temozolomide—Urinary tract disorder—Epirubicin—uterine cancer	0.000267	0.000456	CcSEcCtD
Temozolomide—Oedema peripheral—Epirubicin—uterine cancer	0.000266	0.000455	CcSEcCtD
Temozolomide—Connective tissue disorder—Epirubicin—uterine cancer	0.000265	0.000454	CcSEcCtD
Temozolomide—Urethral disorder—Epirubicin—uterine cancer	0.000265	0.000453	CcSEcCtD
Temozolomide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000263	0.00045	CcSEcCtD
Temozolomide—Sinusitis—Doxorubicin—uterine cancer	0.000261	0.000447	CcSEcCtD
Temozolomide—Visual impairment—Epirubicin—uterine cancer	0.00026	0.000445	CcSEcCtD
Temozolomide—Erythema multiforme—Epirubicin—uterine cancer	0.000255	0.000437	CcSEcCtD
Temozolomide—Eye disorder—Epirubicin—uterine cancer	0.000252	0.000432	CcSEcCtD
Temozolomide—Hypersensitivity—Etoposide—uterine cancer	0.000252	0.000432	CcSEcCtD
Temozolomide—Tinnitus—Epirubicin—uterine cancer	0.000252	0.000431	CcSEcCtD
Temozolomide—Haemoglobin—Doxorubicin—uterine cancer	0.000251	0.00043	CcSEcCtD
Temozolomide—Flushing—Epirubicin—uterine cancer	0.000251	0.000429	CcSEcCtD
Temozolomide—Cardiac disorder—Epirubicin—uterine cancer	0.000251	0.000429	CcSEcCtD
Temozolomide—Hepatitis—Doxorubicin—uterine cancer	0.00025	0.000428	CcSEcCtD
Temozolomide—Haemorrhage—Doxorubicin—uterine cancer	0.00025	0.000428	CcSEcCtD
Temozolomide—Hypoaesthesia—Doxorubicin—uterine cancer	0.000249	0.000425	CcSEcCtD
Temozolomide—Pharyngitis—Doxorubicin—uterine cancer	0.000248	0.000424	CcSEcCtD
Temozolomide—Urinary tract disorder—Doxorubicin—uterine cancer	0.000247	0.000422	CcSEcCtD
Temozolomide—Oedema peripheral—Doxorubicin—uterine cancer	0.000246	0.000421	CcSEcCtD
Temozolomide—Asthenia—Etoposide—uterine cancer	0.000246	0.00042	CcSEcCtD
Temozolomide—Connective tissue disorder—Doxorubicin—uterine cancer	0.000246	0.00042	CcSEcCtD
Temozolomide—Angiopathy—Epirubicin—uterine cancer	0.000245	0.000419	CcSEcCtD
Temozolomide—Urethral disorder—Doxorubicin—uterine cancer	0.000245	0.000419	CcSEcCtD
Temozolomide—Immune system disorder—Epirubicin—uterine cancer	0.000244	0.000417	CcSEcCtD
Temozolomide—Mediastinal disorder—Epirubicin—uterine cancer	0.000243	0.000416	CcSEcCtD
Temozolomide—Chills—Epirubicin—uterine cancer	0.000242	0.000415	CcSEcCtD
Temozolomide—Pruritus—Etoposide—uterine cancer	0.000242	0.000414	CcSEcCtD
Temozolomide—Visual impairment—Doxorubicin—uterine cancer	0.000241	0.000412	CcSEcCtD
Temozolomide—Alopecia—Epirubicin—uterine cancer	0.000239	0.000408	CcSEcCtD
Temozolomide—Mental disorder—Epirubicin—uterine cancer	0.000237	0.000405	CcSEcCtD
Temozolomide—Erythema multiforme—Doxorubicin—uterine cancer	0.000236	0.000404	CcSEcCtD
Temozolomide—Erythema—Epirubicin—uterine cancer	0.000235	0.000402	CcSEcCtD
Temozolomide—Malnutrition—Epirubicin—uterine cancer	0.000235	0.000402	CcSEcCtD
Temozolomide—Diarrhoea—Etoposide—uterine cancer	0.000234	0.000401	CcSEcCtD
Temozolomide—Eye disorder—Doxorubicin—uterine cancer	0.000234	0.0004	CcSEcCtD
Temozolomide—Tinnitus—Doxorubicin—uterine cancer	0.000233	0.000399	CcSEcCtD
Temozolomide—Flushing—Doxorubicin—uterine cancer	0.000232	0.000397	CcSEcCtD
Temozolomide—Cardiac disorder—Doxorubicin—uterine cancer	0.000232	0.000397	CcSEcCtD
Temozolomide—Dysgeusia—Epirubicin—uterine cancer	0.00023	0.000394	CcSEcCtD
Temozolomide—Back pain—Epirubicin—uterine cancer	0.000227	0.000389	CcSEcCtD
Temozolomide—Angiopathy—Doxorubicin—uterine cancer	0.000227	0.000388	CcSEcCtD
Temozolomide—Dizziness—Etoposide—uterine cancer	0.000226	0.000387	CcSEcCtD
Temozolomide—Immune system disorder—Doxorubicin—uterine cancer	0.000226	0.000386	CcSEcCtD
Temozolomide—Mediastinal disorder—Doxorubicin—uterine cancer	0.000225	0.000385	CcSEcCtD
Temozolomide—Chills—Doxorubicin—uterine cancer	0.000224	0.000384	CcSEcCtD
Temozolomide—Vision blurred—Epirubicin—uterine cancer	0.000222	0.000379	CcSEcCtD
Temozolomide—Alopecia—Doxorubicin—uterine cancer	0.000221	0.000378	CcSEcCtD
Temozolomide—Mental disorder—Doxorubicin—uterine cancer	0.000219	0.000375	CcSEcCtD
Temozolomide—Ill-defined disorder—Epirubicin—uterine cancer	0.000218	0.000373	CcSEcCtD
Temozolomide—Vomiting—Etoposide—uterine cancer	0.000218	0.000372	CcSEcCtD
Temozolomide—Erythema—Doxorubicin—uterine cancer	0.000218	0.000372	CcSEcCtD
Temozolomide—Malnutrition—Doxorubicin—uterine cancer	0.000218	0.000372	CcSEcCtD
Temozolomide—Anaemia—Epirubicin—uterine cancer	0.000217	0.000372	CcSEcCtD
Temozolomide—Agitation—Epirubicin—uterine cancer	0.000216	0.00037	CcSEcCtD
Temozolomide—Rash—Etoposide—uterine cancer	0.000216	0.000369	CcSEcCtD
Temozolomide—Dermatitis—Etoposide—uterine cancer	0.000216	0.000369	CcSEcCtD
Temozolomide—Headache—Etoposide—uterine cancer	0.000214	0.000367	CcSEcCtD
Temozolomide—Dysgeusia—Doxorubicin—uterine cancer	0.000213	0.000364	CcSEcCtD
Temozolomide—Malaise—Epirubicin—uterine cancer	0.000212	0.000363	CcSEcCtD
Temozolomide—Vertigo—Epirubicin—uterine cancer	0.000211	0.000361	CcSEcCtD
Temozolomide—Leukopenia—Epirubicin—uterine cancer	0.00021	0.00036	CcSEcCtD
Temozolomide—Back pain—Doxorubicin—uterine cancer	0.00021	0.00036	CcSEcCtD
Temozolomide—Palpitations—Epirubicin—uterine cancer	0.000208	0.000355	CcSEcCtD
Temozolomide—Cough—Epirubicin—uterine cancer	0.000205	0.000351	CcSEcCtD
Temozolomide—Vision blurred—Doxorubicin—uterine cancer	0.000205	0.000351	CcSEcCtD
Temozolomide—Convulsion—Epirubicin—uterine cancer	0.000204	0.000349	CcSEcCtD
Temozolomide—Nausea—Etoposide—uterine cancer	0.000203	0.000348	CcSEcCtD
Temozolomide—Hypertension—Epirubicin—uterine cancer	0.000203	0.000347	CcSEcCtD
Temozolomide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000202	0.000345	CcSEcCtD
Temozolomide—Anaemia—Doxorubicin—uterine cancer	0.000201	0.000344	CcSEcCtD
Temozolomide—Myalgia—Epirubicin—uterine cancer	0.0002	0.000342	CcSEcCtD
Temozolomide—Arthralgia—Epirubicin—uterine cancer	0.0002	0.000342	CcSEcCtD
Temozolomide—Agitation—Doxorubicin—uterine cancer	0.0002	0.000342	CcSEcCtD
Temozolomide—Anxiety—Epirubicin—uterine cancer	0.000199	0.000341	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000199	0.00034	CcSEcCtD
Temozolomide—Discomfort—Epirubicin—uterine cancer	0.000198	0.000338	CcSEcCtD
Temozolomide—Malaise—Doxorubicin—uterine cancer	0.000196	0.000336	CcSEcCtD
Temozolomide—Dry mouth—Epirubicin—uterine cancer	0.000196	0.000335	CcSEcCtD
Temozolomide—Vertigo—Doxorubicin—uterine cancer	0.000195	0.000334	CcSEcCtD
Temozolomide—Leukopenia—Doxorubicin—uterine cancer	0.000195	0.000333	CcSEcCtD
Temozolomide—Confusional state—Epirubicin—uterine cancer	0.000193	0.000331	CcSEcCtD
Temozolomide—Palpitations—Doxorubicin—uterine cancer	0.000192	0.000329	CcSEcCtD
Temozolomide—Oedema—Epirubicin—uterine cancer	0.000192	0.000328	CcSEcCtD
Temozolomide—Anaphylactic shock—Epirubicin—uterine cancer	0.000192	0.000328	CcSEcCtD
Temozolomide—Infection—Epirubicin—uterine cancer	0.000191	0.000326	CcSEcCtD
Temozolomide—Cough—Doxorubicin—uterine cancer	0.00019	0.000325	CcSEcCtD
Temozolomide—Convulsion—Doxorubicin—uterine cancer	0.000188	0.000322	CcSEcCtD
Temozolomide—Nervous system disorder—Epirubicin—uterine cancer	0.000188	0.000322	CcSEcCtD
Temozolomide—Thrombocytopenia—Epirubicin—uterine cancer	0.000188	0.000321	CcSEcCtD
Temozolomide—Hypertension—Doxorubicin—uterine cancer	0.000188	0.000321	CcSEcCtD
Temozolomide—Skin disorder—Epirubicin—uterine cancer	0.000186	0.000319	CcSEcCtD
Temozolomide—Hyperhidrosis—Epirubicin—uterine cancer	0.000185	0.000317	CcSEcCtD
Temozolomide—Arthralgia—Doxorubicin—uterine cancer	0.000185	0.000317	CcSEcCtD
Temozolomide—Myalgia—Doxorubicin—uterine cancer	0.000185	0.000317	CcSEcCtD
Temozolomide—Anxiety—Doxorubicin—uterine cancer	0.000185	0.000316	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000184	0.000315	CcSEcCtD
Temozolomide—Discomfort—Doxorubicin—uterine cancer	0.000183	0.000313	CcSEcCtD
Temozolomide—Anorexia—Epirubicin—uterine cancer	0.000183	0.000313	CcSEcCtD
Temozolomide—Dry mouth—Doxorubicin—uterine cancer	0.000181	0.00031	CcSEcCtD
Temozolomide—Confusional state—Doxorubicin—uterine cancer	0.000179	0.000306	CcSEcCtD
Temozolomide—Oedema—Doxorubicin—uterine cancer	0.000178	0.000304	CcSEcCtD
Temozolomide—Anaphylactic shock—Doxorubicin—uterine cancer	0.000178	0.000304	CcSEcCtD
Temozolomide—Infection—Doxorubicin—uterine cancer	0.000176	0.000302	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000175	0.000299	CcSEcCtD
Temozolomide—Nervous system disorder—Doxorubicin—uterine cancer	0.000174	0.000298	CcSEcCtD
Temozolomide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000174	0.000297	CcSEcCtD
Temozolomide—Insomnia—Epirubicin—uterine cancer	0.000174	0.000297	CcSEcCtD
Temozolomide—Skin disorder—Doxorubicin—uterine cancer	0.000172	0.000295	CcSEcCtD
Temozolomide—Paraesthesia—Epirubicin—uterine cancer	0.000172	0.000295	CcSEcCtD
Temozolomide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000172	0.000294	CcSEcCtD
Temozolomide—Dyspnoea—Epirubicin—uterine cancer	0.000171	0.000293	CcSEcCtD
Temozolomide—Somnolence—Epirubicin—uterine cancer	0.000171	0.000292	CcSEcCtD
Temozolomide—Anorexia—Doxorubicin—uterine cancer	0.000169	0.00029	CcSEcCtD
Temozolomide—Dyspepsia—Epirubicin—uterine cancer	0.000169	0.000289	CcSEcCtD
Temozolomide—Decreased appetite—Epirubicin—uterine cancer	0.000167	0.000285	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000166	0.000283	CcSEcCtD
Temozolomide—Fatigue—Epirubicin—uterine cancer	0.000165	0.000283	CcSEcCtD
Temozolomide—Pain—Epirubicin—uterine cancer	0.000164	0.000281	CcSEcCtD
Temozolomide—Constipation—Epirubicin—uterine cancer	0.000164	0.000281	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000162	0.000277	CcSEcCtD
Temozolomide—Insomnia—Doxorubicin—uterine cancer	0.000161	0.000275	CcSEcCtD
Temozolomide—Paraesthesia—Doxorubicin—uterine cancer	0.000159	0.000273	CcSEcCtD
Temozolomide—Dyspnoea—Doxorubicin—uterine cancer	0.000158	0.000271	CcSEcCtD
Temozolomide—Feeling abnormal—Epirubicin—uterine cancer	0.000158	0.000271	CcSEcCtD
Temozolomide—Somnolence—Doxorubicin—uterine cancer	0.000158	0.00027	CcSEcCtD
Temozolomide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000157	0.000268	CcSEcCtD
Temozolomide—Dyspepsia—Doxorubicin—uterine cancer	0.000156	0.000267	CcSEcCtD
Temozolomide—Decreased appetite—Doxorubicin—uterine cancer	0.000154	0.000264	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000153	0.000262	CcSEcCtD
Temozolomide—Fatigue—Doxorubicin—uterine cancer	0.000153	0.000262	CcSEcCtD
Temozolomide—Urticaria—Epirubicin—uterine cancer	0.000152	0.000261	CcSEcCtD
Temozolomide—Constipation—Doxorubicin—uterine cancer	0.000152	0.00026	CcSEcCtD
Temozolomide—Pain—Doxorubicin—uterine cancer	0.000152	0.00026	CcSEcCtD
Temozolomide—Abdominal pain—Epirubicin—uterine cancer	0.000152	0.00026	CcSEcCtD
Temozolomide—Body temperature increased—Epirubicin—uterine cancer	0.000152	0.00026	CcSEcCtD
Temozolomide—Feeling abnormal—Doxorubicin—uterine cancer	0.000146	0.00025	CcSEcCtD
Temozolomide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000145	0.000248	CcSEcCtD
Temozolomide—Hypersensitivity—Epirubicin—uterine cancer	0.000141	0.000242	CcSEcCtD
Temozolomide—Urticaria—Doxorubicin—uterine cancer	0.000141	0.000241	CcSEcCtD
Temozolomide—Body temperature increased—Doxorubicin—uterine cancer	0.00014	0.00024	CcSEcCtD
Temozolomide—Abdominal pain—Doxorubicin—uterine cancer	0.00014	0.00024	CcSEcCtD
Temozolomide—Asthenia—Epirubicin—uterine cancer	0.000138	0.000236	CcSEcCtD
Temozolomide—Pruritus—Epirubicin—uterine cancer	0.000136	0.000232	CcSEcCtD
Temozolomide—Diarrhoea—Epirubicin—uterine cancer	0.000131	0.000225	CcSEcCtD
Temozolomide—Hypersensitivity—Doxorubicin—uterine cancer	0.000131	0.000224	CcSEcCtD
Temozolomide—Asthenia—Doxorubicin—uterine cancer	0.000127	0.000218	CcSEcCtD
Temozolomide—Dizziness—Epirubicin—uterine cancer	0.000127	0.000217	CcSEcCtD
Temozolomide—Pruritus—Doxorubicin—uterine cancer	0.000126	0.000215	CcSEcCtD
Temozolomide—Vomiting—Epirubicin—uterine cancer	0.000122	0.000209	CcSEcCtD
Temozolomide—Diarrhoea—Doxorubicin—uterine cancer	0.000121	0.000208	CcSEcCtD
Temozolomide—Rash—Epirubicin—uterine cancer	0.000121	0.000207	CcSEcCtD
Temozolomide—Dermatitis—Epirubicin—uterine cancer	0.000121	0.000207	CcSEcCtD
Temozolomide—Headache—Epirubicin—uterine cancer	0.00012	0.000206	CcSEcCtD
Temozolomide—Dizziness—Doxorubicin—uterine cancer	0.000117	0.000201	CcSEcCtD
Temozolomide—Nausea—Epirubicin—uterine cancer	0.000114	0.000195	CcSEcCtD
Temozolomide—Vomiting—Doxorubicin—uterine cancer	0.000113	0.000193	CcSEcCtD
Temozolomide—Rash—Doxorubicin—uterine cancer	0.000112	0.000192	CcSEcCtD
Temozolomide—Dermatitis—Doxorubicin—uterine cancer	0.000112	0.000191	CcSEcCtD
Temozolomide—Headache—Doxorubicin—uterine cancer	0.000111	0.00019	CcSEcCtD
Temozolomide—Nausea—Doxorubicin—uterine cancer	0.000105	0.00018	CcSEcCtD
